ºÚÁϳԹÏÍø

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • ºÚÁϳԹÏÍø News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Dec 6 2023

Full Issue

Health Agency Warns About Possibility Of Unsafe Swine Vaccines; Old Drug Gets The Go-Ahead For STI Prevention

Read recent pharmaceutical developments in ºÚÁϳԹÏÍø News' Prescription Drug Watch roundup.

The World Organisation for Animal Health (WOAH) is warning that more testing of African swine fever vaccines is needed, triggered by Vietnam's plans to export doses in coming months to fight a disease that regularly ravages pig farms worldwide. In a world first, Vietnam authorised in July two attenuated live-virus vaccines against the disease, which is not deadly to humans but is extremely infectious among pigs and has caused repeated disruptions to the global pork market, which data provider Research and Markets said was worth about $250 billion in 2022. (Guarascio, Vu and Flores, 12/6)

Sometime next year, the Centers for Disease Control and Prevention (CDC) will publish guidelines for one of the first new sexually transmitted infection (STI) prevention tools in decades. The tool—the tetracycline antibiotic doxycycline—is not new. In fact, it was first approved by the Food and Drug Administration in 1967 and has since then been used to treat a variety of bacterial infections, from respiratory infections to skin infections and STIs like chlamydia and syphilis. Safe, inexpensive, and widely available, it's the most commonly used tetracycline and is on the World Health Organization's list of essential medicines. (Dall, 12/4)

The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinso is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health's Monoject syringes. The health regulator said Alaris pumps are validated for use with Monoject syringes. However, the dimensions for Monoject syringes have recently changed while rebranding the syringes from Covidien Monoject to Cardinal Health Monoject. (12/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • ºÚÁϳԹÏÍø
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF